Innovative nanotools for vascular drug delivery: the atherosclerosis case study

J Mater Chem B. 2021 Oct 27;9(41):8558-8568. doi: 10.1039/d1tb01071a.

Abstract

Cardiovascular diseases are the leading cause of mortality in the Western world. Among them, atherosclerosis represents one of the most common diseases in the modern society due to a common sedentary lifestyle, high-fat diet, and smoking. In the near future, a new approach could potentially improve the therapy of vascular pathologies, where to date the non-specific treatments present several limitations, such as poor biodistribution, quick elimination from the body, and undesired side-effects. In this field, nanotechnology has a great potential for the therapy and diagnosis of atherosclerosis with more and more recent and innovative publications. This review is a critical analysis of the results reported in the literature regarding the different and possible new approaches for the therapy and diagnosis of atherosclerosis.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / therapeutic use*
  • Atherosclerosis / drug therapy*
  • Atherosclerosis / pathology
  • Drug Delivery Systems*
  • Humans
  • Nanoparticles / chemistry*
  • Nanotechnology*

Substances

  • Anti-Inflammatory Agents